Form 4: Design Therapeutics Director Heather A. Berger Acquires 1,300 Shares
SEC Form 4 Filing
Director Heather A. Berger purchased 1,300 shares of Design Therapeutics, Inc. on March 25, 2024.
Summary
- On March 25, 2024, Heather A. Berger, a director of Design Therapeutics, Inc. (DSGN), acquired 1,300 shares of common stock.
- The purchase price was $3.7429 per share.
- Following the transaction, Ms. Berger directly owns 1,300 shares of Design Therapeutics.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of an insider transaction. The purchase itself is a slightly positive signal, but the information is limited.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider transactions are closely watched by investors as they can provide insights into a company's prospects, as seen by its executives and directors.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/25/2024 | Date of the transaction: Heather A. Berger acquired 1,300 shares of Design Therapeutics, Inc. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.